chr12-39647842-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001031748.4(C12orf40):āc.435A>Gā(p.Ile145Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000934 in 1,606,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001031748.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C12orf40 | NM_001031748.4 | c.435A>G | p.Ile145Met | missense_variant | 6/13 | ENST00000324616.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C12orf40 | ENST00000324616.9 | c.435A>G | p.Ile145Met | missense_variant | 6/13 | 1 | NM_001031748.4 | P1 | |
C12orf40 | ENST00000405531.7 | c.435A>G | p.Ile145Met | missense_variant | 6/11 | 1 | |||
C12orf40 | ENST00000468200.2 | c.204A>G | p.Ile68Met | missense_variant, NMD_transcript_variant | 5/19 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152060Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000823 AC: 2AN: 242986Hom.: 0 AF XY: 0.00000757 AC XY: 1AN XY: 132094
GnomAD4 exome AF: 0.00000757 AC: 11AN: 1453982Hom.: 0 Cov.: 30 AF XY: 0.00000691 AC XY: 5AN XY: 723478
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152060Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 14, 2021 | The c.435A>G (p.I145M) alteration is located in exon 6 (coding exon 6) of the C12orf40 gene. This alteration results from a A to G substitution at nucleotide position 435, causing the isoleucine (I) at amino acid position 145 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at